Woman, 47, Suffered Physically and Emotionally for Years from Psoriasis. Then, One Decision Changed Everything (Exclusive)
Yahoo • • health
Key Points:
- Amber Dean, who suffered from plaque psoriasis for years with worsening symptoms and emotional distress, found relief after joining a clinical trial for ICOTYDE, the first FDA-approved oral medication for moderate-to-severe plaque psoriasis.
- Dean's condition caused painful, itchy skin patches that affected her daily life and self-confidence, leading her to wear long clothing to hide the plaques and feel judged by others.
- Despite trying various treatments that only provided temporary relief, Dean experienced a significant improvement with ICOTYDE, reporting completely clear skin and no residual symptoms.
- Dean emphasizes that plaque psoriasis is a disease that does not define a person and encourages others to seek new treatment options without shame or embarrassment.
- Her decision to join the clinical trial was life-changing, highlighting the importance of perseverance and awareness of emerging therapies for chronic autoimmune conditions.
